Supernus Pharmaceuticals, Inc. (FRA:S49)

Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,205	1,929	1,430	1,804	1,364	1,084
Market Cap Growth	11.98%	34.83%	-20.72%	32.32%	25.83%	-2.28%
Enterprise Value	1,999	1,576	1,265	1,730	991	833
Last Close Price	39.20	35.60	26.40	33.40	26.40	20.20
PE Ratio	-	27.03	1201.42	31.76	29.03	10.44
PS Ratio	3.80	3.02	2.60	2.89	2.68	2.55
PB Ratio	2.46	1.93	1.72	2.18	1.90	1.78
P/TBV Ratio	8.42	5.03	7.73	28.90	-	4.38
P/FCF Ratio	36.56	11.66	14.30	16.56	12.40	9.84
P/OCF Ratio	35.99	11.61	14.23	16.51	12.20	9.58
EV/Sales Ratio	3.41	2.47	2.30	2.77	1.95	1.96
EV/EBITDA Ratio	17.41	11.51	14.23	14.10	10.06	5.26
EV/EBIT Ratio	69.28	26.59	104.31	40.53	14.18	5.80
EV/FCF Ratio	33.15	9.53	12.65	15.88	9.01	7.56
Debt / Equity Ratio	0.04	0.03	0.05	0.51	0.54	0.59
Debt / EBITDA Ratio	0.32	0.22	0.37	3.13	3.55	2.17
Debt / FCF Ratio	0.60	0.20	0.38	3.87	3.52	3.24
Asset Turnover	0.49	0.50	0.41	0.39	0.36	0.39
Inventory Turnover	1.06	1.18	0.99	0.98	1.12	1.40
Quick Ratio	1.37	2.04	1.38	0.91	1.55	2.30
Current Ratio	1.80	2.35	1.70	1.07	1.91	2.57
Return on Equity (ROE)	-1.86%	7.55%	0.15%	7.13%	6.85%	18.94%
Return on Assets (ROA)	1.52%	2.90%	0.56%	1.68%	3.11%	8.24%
Return on Capital (ROIC)	1.96%	3.77%	0.73%	2.20%	4.08%	10.08%
Return on Capital Employed (ROCE)	3.10%	5.70%	1.40%	4.50%	5.80%	13.90%
Earnings Yield	-0.74%	3.70%	0.08%	3.15%	3.45%	9.58%
FCF Yield	2.74%	8.58%	6.99%	6.04%	8.07%	10.16%
Buyback Yield / Dilution	-0.54%	-0.81%	10.01%	-13.47%	-1.24%	0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.